COH Share Price

Open 176.23 Change Price %
High 176.76 1 Day -1.27 -0.72
Low 173.63 1 Week 0.00 0.00
Close 174.65 1 Month 7.35 4.39
Volume 133541 1 Year 50.71 40.91
52 Week High 177.59
52 Week Low 112.51
COH Important Levels
Resistance 2 177.55
Resistance 1 176.36
Pivot 175.01
Support 1 172.94
Support 2 171.75
ASX Australia Most Active Stocks
COE 0.30 3.45%
COE 0.30 3.45%
GPP 0.02 0.00%
DUE 3.02 1.00%
DUE 3.02 1.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
XST 0.02 100.00%
XST 0.02 100.00%
ATP 0.03 50.00%
ATP 0.03 50.00%
PMQ 0.03 50.00%
RMI 0.03 50.00%
RMI 0.03 50.00%
BNV 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
EMG 0.01 -50.00%
GDY 0.01 -50.00%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 5
As on 1st Nov 2017 COH Share Price closed @ 174.65 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 143.18 & Strong Buy for SHORT-TERM with Stoploss of 161.98 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for November
1st Target up-side 185.99
2nd Target up-side 193.04
3rd Target up-side 200.1
1st Target down-side 165.85
2nd Target down-side 158.8
3rd Target down-side 151.74
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.